Reporting owner · Q3 2026 · CIK 1877188

Webster Brian Daniel: insider trades.

Webster Brian Daniel reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($2.7M), across 1 company.

Transactions
11
Purchases (P)
0
Sales (S)
10
Companies
1
Name as filed
Webster Brian Daniel

Companies

CompanyRelationshipTransactions
Kestra Medical Technologies, Ltd. (KMTS)Director, Officer · See Remarks11

Transactions

11 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-17Kestra Medical Technologies, Ltd.S15,000$27.48460,215Form 4
2026-08-04Kestra Medical Technologies, Ltd.S48,625$24.47478,490Form 4
2026-08-04Kestra Medical Technologies, Ltd.S442$25.98475,215Form 4
2026-08-04Kestra Medical Technologies, Ltd.S2,833$25.16475,657Form 4
2026-08-03Kestra Medical Technologies, Ltd.S13,017$23.92527,115Form 4
2026-07-31Kestra Medical Technologies, Ltd.S8,948$22.6540,132Form 4
2026-07-30Kestra Medical Technologies, Ltd.S7,857$22.72549,080Form 4
2026-07-15Kestra Medical Technologies, Ltd.S11,216$22.01560,721Form 4
2026-07-15Kestra Medical Technologies, Ltd.A176,470$0571,937Form 4
2026-07-15Kestra Medical Technologies, Ltd.S3,000$24556,937Form 4
2026-07-15Kestra Medical Technologies, Ltd.S784$22.63559,937Form 4

Questions

What stock did Webster Brian Daniel buy or sell?

Webster Brian Daniel reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($2.7M), across 1 company.

Is Webster Brian Daniel the same person as other filers with this name?

This page covers SEC CIK 1877188 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/webster-brian-daniel-1877188.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.